Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
ESMO Open|March 13, 2021
Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers NetworkA M Frezza, A Napolitano, R Miceli, et al.
ESMO Open|January 23, 2025
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus StudyL Incorvaia, C Marchetti, C Brando, et al.
ESMO Open|August 9, 2021
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedgeM Bono, D Fanale, L Incorvaia, et al.
ESMO Open|August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world studyM Nannini, A Rizzo, M C Nigro, et al.
ESMO Open|October 23, 2024
Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centersL Algeri, L Falkman, F Spada, et al.
ESMO Open|December 20, 2023
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)L Incorvaia, G Badalamenti, G Novo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumourS Stacchiotti, M Tortoreto, G G Baldi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2017
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumourS Stacchiotti, M Saponara, R Frapolli, et al.
Journal of Endocrinological Investigation|August 18, 2020
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)F Panzuto, M Maccauro, D Campana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma GroupL D'Ambrosio, A Merlini, A Brunello, et al.
Pageof 3